Condition
Statin Therapy
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (4)
P 4 (2)
Trial Status
Recruiting3
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07717788Not ApplicableCompleted
Therapeutic Prospects of HMG-CoA Reductase Inhibitors, Atorvastatin and Rosuvastatin, in Osteoporotic Patients
NCT06684106Not ApplicableRecruiting
Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance
NCT06603363Not ApplicableRecruiting
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NCT06804980Phase 4RecruitingPrimary
DESIFOR-EXPAND (MHIF)
NCT01509014Not ApplicableUnknownPrimary
Community Pharmacy Assisting in Total Cardiovascular Health
NCT00113477Phase 4CompletedPrimary
The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy
Showing all 6 trials